Clinical trial · Interventional
Classic Total Thyroidectomy With or Without Drains
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Protocol Synopsis * Design: Prospective, single-center randomized study Patient Population: Male or female subjects 18 years of age or older who are scheduled for total thyroidectomy * No. of Subjects: 100 patients divided into two groups, estimated up to 6 months to enroll * Duration of Treatment: During the operation * Duration of Follow-up: Follow-up will be performed daily while hospitalized, and by phone till the 7th postoperative day * Endpoints: To evaluate the safety and cost-effectiveness of each technique
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Goiter | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Total thyroidectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- A
- description
- Classic thyroidectomy with drains
- interventionNames
- Procedure: Total thyroidectomy
- type
- ACTIVE_COMPARATOR
- label
- B
- description
- Classic thyroidectomy without drains
- interventionNames
- Procedure: Total thyroidectomy
Primary outcomes (1)
- measure
- Assess the necessity of the use of drains in large goiters
- timeFrame
- 7days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient is over 18 years old 2. Patient scheduled for a non-emergency operation 3. Patient signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures Exclusion Criteria: 1. Patient had a previous thyroid operation 2. Patient is participating in another clinical trial which may affect this study's outcomes 3. Patient in toxic condition 4. Patient receiving anticoagulation treatment for other medical condition
References
Publications (0)
Data not yet available